Matthew Paul Larson - 22 Oct 2026 Form 4 Insider Report for Slide Insurance Holdings, Inc. (SLDE)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
23 Oct 2026, 16:18:10 UTC
Prior SEC filing
22 Oct 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Anastasios Omiridis, Attorney-in-Fact for Matthew Larson
Filing notes and source

Key filing fact

Matthew Paul Larson filed Form 4 for Slide Insurance Holdings, Inc. (SLDE) on 23 Oct 2026.

Key facts

  • This page summarizes Matthew Paul Larson's Form 4 filing for Slide Insurance Holdings, Inc. (SLDE).
  • 3 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 23 Oct 2026, 16:18.

Change

  • Previous filing in this sequence was filed on 22 Oct 2026.
  • Current net transaction value: -$307,182.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002114934 Primary reporting owner

LARSON MATTHEW PAUL

Relationship
Chief Risk Officer
Address
4221 W BOY SCOUT BLVD, SUITE 200, TAMPA
Signature
/s/ Anastasios Omiridis, Attorney-in-Fact for Matthew Larson
Signature date
23 Oct 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SLDE transaction

Common Stock

Options Exercise

Transaction value
Shares
+11,150
Change %
Price
$1.38*
Shares after
11,150
Date
22 Oct 2026
Ownership
Direct
SLDE transaction

Common Stock

Sale

Transaction value
-$307,182
Shares
-11,150
Change %
-100%
Price
$27.55
Shares after
0
Date
22 Oct 2026
Ownership
Direct
Footnotes
F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

SLDE transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
Shares
-11,150
Change %
-45%
Price
$0.000000*
Shares after
13,750
Date
22 Oct 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
11,150
Exercise price
$1.38
Footnotes
F1, F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 3 footnotes

Footnote F1

Exercised and sold pursuant to a 10b5-1 trading plan adopted by the Reporting Person on May 4, 2026.

Footnote F2

Represents the weighted average price of the shares sold. The prices of the shares sold pursuant to the transactions ranges from $27.50 to $27.62 per share. The Reporting Person, upon request, will provide the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.

Footnote F3

Of the 24,900 stock options reported herein, 11,150 are vested and exercisable. The remaining 13,750 vest on July 14, 2027.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .